Complement Activation and Release of Interleukin-6 and Tumour Necrosis Factor-a in Drained and Systemic Blood after Major Orthopaedic Surgery

REFERENCES

• Arnestad JP, Bengtsson A, Bengtson JP, et al. Formation of cytokines by retransfusion of shed whole blood. Br J Anaesth 1994; 72: 422–425.
   Google Scholar
• Amestad JP, Bengtsson A, Bengtson JP, et al. Release of cytokines, polymorphonuclear elastase and terminal C5b-9 complement complex by infusion of wound drainage blood. Acta Orthop Scand 1995; 66; 4: 334–338.
   Google Scholar
• Ashcroft GS, Masterson GR. Interleukin-6 and wound healing. Br J Anaesth 1994; 73: 426–432.
   Google Scholar
• Atkinson JP, Farries T. Separation of self from non-self in the complement system. Immunol Today 1987; 8: 212–215.
   PubMedGoogle Scholar
• Baigrie RJ, Lamont PJ, Kwiatkowski D, et al. Systemic cytokine response after major surgery. Br J Surg 1992; 79: 757–760.
   PubMed Web of Science ®Google Scholar
• Bengtsson A, Amestad JP, Rydenhag A, et al. Autologous blood transfusion: Influence on the comple-ment cascade. Labmedica 1991; 8: 25–30.
   Google Scholar
• Cruickshank AM, Fraser WD, Burns HJG, et al. Response of serum Interleukin-6 in patients undergoing elective surgery of varying severity. Clin Science 1990; 79: 161–165.
   PubMed Web of Science ®Google Scholar
• DeBoer JP, Wolbink GJ, Thijs LG, et al. Interplay of complement and cytokines in the patogenesis of septic shock. Immunopharmacol 1992; 24: 135–148.
   Google Scholar
• Dhainaut JFA, Vincent JL, Richard C, et al. CPD571, a humanized antibody to human tumor necrosis factor alpha: safety, pharmacokinetics, immune response, and influence of the antibody on cytokine concentrations in patients with septic shock. Crit Care Med 1995; 23: 1461–1469.
   PubMed Web of Science ®Google Scholar
• Fong Y, Lowry SF. Tumor necrosis factor in the pathophysiology of infection and sepsis. Clin Immunol Immunopathol 1990; 55: 157–170.
   PubMedGoogle Scholar
• Fosse E, Mollnes TE, Ingvaldsen B. Complement activation during major surgery with or without cardio-pulmonary bypass. J Thorac Cardiovasc Surg 1987; 93: 860–866.
   PubMed Web of Science ®Google Scholar
• Gardinali M, Calcagno A, Conciato L, et al. Comple-ment activation in dialysis: effects on cytokines, lymfocyte activation and beta 2 microglobulin. Int J Artific Org 1994; 17: 337–344.
   PubMed Web of Science ®Google Scholar
• Garred P. Mollnes TE, Lea T. Quantification in enzyme-linked immunosorbent assay of a C3 neoepitope expressed on activated human complement factor C3. Scand J Immunol 1988; 27: 329–335.
   Google Scholar
• Gennary R, Wesley A. Anti-interleukin-6 antibody treatment improves survival during gut-derived sepsis in a time-dependent matter by enhancing host defense. Crit Care Med 1995; 23: 1945-1953.
   Google Scholar
• Hogevold HE. Studies on the acute phase response in total hip replacement surgery. Oslo: University of Oslo, 1996. Thesis.
   Google Scholar
• Le J, Vilcek J. Interleukin 6: a multifunctional cytokine regulating immune reactions and the acute phase protein response. Lab Invest 1989; 61: 588–602.
   PubMed Web of Science ®Google Scholar
• Lundberg L, Johansen G, Karlsson L, et al. Complement activation is influenced by the membrane material, design of the dialyzer, sterilizing method and type of dialysate. Nephrol Dialys Transplant 1994; 9: 1310–1314.
   PubMedGoogle Scholar
• Moat NE, Shore DF, Evans TW. Organ dysfunction and cardiopulmonary bypass: the role of complement and complement regulatory proteins. Eur J Cardiothor Surg 1993; 7: 563–573.
   Google Scholar
• Mollnes TE, Fosse E. The complement system in trauma-related and ischemic tissue damage: a brief review. Shock 1994; 2: 301–310.
   PubMed Web of Science ®Google Scholar
• Mollnes TE, Lea T, Froland S, Harboe M. Quantification of terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on onoclonal antibodies against a neoantigen of the complex. Scand J Immunol 1985; 22: 197–202.
   PubMed Web of Science ®Google Scholar
• Morgan BP. Complement membrane attack on nucleated cells: resistance, recovery and nonlethal effects. Bio-chem J 1989; 264: 1–14.
   PubMed Web of Science ®Google Scholar
• Okusawa S, Yancey KB, van der Meer JVVM, et al. C5a stimulates secretion of tumor necrosis factor from human mononuclear cells in vitro. J Exp Med 1988; 168: 443–448.
   Google Scholar
• Romani S. Lymphokine production by human cells in disease states. Ann Rev Immunol. 1994; 12: 227–257.
   Google Scholar
• Rudi MJR, Thijs H, van der Ven-Jongekrijg J, et al. Cytokine patterns in patients after major vascular surgery, hemorrhagic shock and severe blunt trauma. Ann Surg 1993; 218: 6: 769–776.
   Google Scholar
• Saatvedt K, Lindberg H, Geiran OR, et al. Complement activation and release of tumor necrosis factor and interleukin-2 receptors, during and after cardiopulmon-ary bypass in children. Scan J Clin Lab Invest 1995; 55: 79–86.
   PubMed Web of Science ®Google Scholar
• Scholz W, McClurg MR, Cardenas GJ, et al. C5a-mediated release of interleukin 6 by human monocytes. Clin Immunol Immunopathol 1990; 57: 297–307.
   PubMedGoogle Scholar
• Steinberg JB, Kapelanski DP, Olson JD, et al. Cytokine and complement levels in patients undergoing cardio-pulmonary bypass. J Thorac Cardiovasc Surg 1993; 106: 1008–1016.
   PubMed Web of Science ®Google Scholar
• Videm V, Fosse E, Mollnes TE, et al. Time for new concepts about measurement of complement activation by cardiopulmonary bypass. Ann Thorac Surg 1992; 54: 725–731.
   Google Scholar
• Waage A, Braendtzweg P. Halstensen A, et al. The complex pattern of cytokines in serum from patients with meningococcal septic shock. J Exp Med 1989; 169: 333–338.
   PubMed Web of Science ®Google Scholar